Now, the new study shows they could be a viable treatment for patients with metabolic dysfunction-associated steatohepatitis (MASH), which occurs when fat builds up in the liver and causes inflammation and scarring
But as healthcare leaders, we have to ask the harder question: If we can save 17,000 lives by managing the disease earlier with medication, how many lives could we transform by reversing it entirely
After several months at a stable dose, most people find side effects minimal or absent
GLP-1 medications slow the rate at which the stomach empties, which means food stays in the stomach longer and fullness signals arrive sooner
indirect improvements in ovulatory function are plausible through weight loss, as seen with other GLP-1 agents in PCOS, but remain unconfirmed
Expect monthly contact with your physician during titration